-
Clostridium Difficile Infection Treatment Market Size Worth US$ 2.28 Billion by 2034 at a CAGR Of 6.3% | Fact.MR Report
23 Jan 2025 12:30 GMT
… vaccines.
Astellas Pharma provides a range of immunotherapeutic medicines, including antibiotics, for the treatment … the market based on drug type (metronidazole, vancomycin, fidaxomicin), route of administration …
-
Blocking Toxin Function and Modulating the Gut Microbiota: Caffeic Acid and its Derivatives as Potential Treatments for Clostridioides difficile Infection
04 Dec 2024 22:46 GMT
… the treatment of CDI, while antibiotics including metronidazole, fidaxomicin and … chemicals, including 1515 FDA-approved drugs and 561 natural … Aiwu Wu, Guangzhou Medical University) was cultured … obtained from Chengdu Ruifensi Biotechnology Co., Ltd. (Chengdu …
-
Two Years After its FDA Approval, Rebyota Continues to Show Efficacy and Safety
18 Nov 2024 22:59 GMT
… the approval. Ferring Pharmaceuticals announced results of its … , investigators reviewed the medical records of 64 adult … Fidaxomicin (57.8%) was the most utilized standard-of-care antibiotic for treatment … validating the randomized control trial from phase 3. …
-
Head-to-Head Comparison of Treatments for Recurrent C difficile Infection
14 Nov 2024 15:31 GMT
… for rCDI. Antibiotics like vancomycin and fidaxomicin showed lower … lack of standardized, FDA-compliant manufacturing processes, which … reported a randomized controlled trial (RCT) involving 153 … treatment strategies for rCDI, including more clinical trials …
-
C diff Treatment: Fidaxomicin's Rise as The Preferred Therapy Post-IDSA Guidelines
03 Oct 2024 14:24 GMT
… The study investigated treatment patterns involving fidaxomicin, vancomycin, and metronidazole … trials. The research focuses on hospitalized patients with CDI, and comparing fidaxomicin … or fidaxomicin as first-line treatments, a study analyzing Medicare …
-
Human medicines European public assessment report (EPAR): Dificlir, fidaxomicin, Date of authorisation: 05/12/2011, Revision: 18, Status: Authorised
30 Sep 2024 13:33 GMT
… and enhance health. However, some antibiotics that are used to treat … active substance in Dificlir, fidaxomicin, is an antibiotic that belongs to the … class of macrocylic antibiotics. When it is swallowed most …
-
Amaran Biotech Makes Its Debut at BioJapan 2024 in Yokohama
25 Sep 2024 09:33 GMT
… Organization) offering comprehensive pharmaceutical development and manufacturing … vaccines, gene therapy drugs, new complex drugs, … trials, which have been accepted by the U.S. FDA. Amaran Biotech … commercialize the antibiotic drug DIFICIDĀ® (Fidaxomicin) in …
-
Immuron Plans Phase 2 Trial for IMM-529 following FDA review
05 Sep 2024 15:54 GMT
… States Food and Drug Administration (FDA) on the pre … spectrum antibiotics worldwide. An unintended consequence of antimicrobial treatment is … , Australia to develop vaccines to produce bovine colostrum … each of fidaxomicin and vancomycin) but some doctors who …
-
Macrolide Antibiotics Market Growth Analysis With Investment Opportunities For 2024-2033
19 Aug 2024 15:45 GMT
… treatment costs, and expand their market reach. Generic formulations of macrolide antibiotics … original branded medications.
Segments:
1) By Drugs: Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, Telithromycin
2 …
-
Clostridium Difficile Infections Market Report 2034: Epidemiology, Pipeline Therapies, Latest Approvals by DelveInsight
13 Jan 2025 12:53 GMT
… Therapeutics, Recursion Pharmaceuticals, and others … antibiotic resistance, vancomycin and fidaxomicin have replaced metronidazole as first-line treatments. Fidaxomicin … New drug candidates, including vaccines and … Current Treatment and Medical Practices
…